Science & Tech · AI · 12 hrs ago
Lianyungang conference explores AI's role in pharmaceutical innovation
Pharmaceutical experts and companies met in Lianyungang, China, on Nov.
8-9 for the eighth Lianyungang Pharmaceutical Technology Conference.
The city is developing its biomedical industry through the “China Pharmaceutical Port” platform, which aims to attract expertise and support research and cooperation.
The conference focused on using artificial intelligence in drug development and the wider pharmaceutical industry, alongside international expansion and domestic supply chains.
Organizers held a main forum and three smaller sessions, with discussions on topics including drug reviews, medical devices and making medicines.
A public service platform for AI and medicine was launched, and two new research and talent platforms were unveiled.
The new platforms are intended to connect research, industry and international partners and support the development of medicines and medical products in China.
The conference also included training and business meetings, but no specific next steps or project outcomes were announced.
The eighth Lianyungang Pharmaceutical Technology Conference was held on November 8 and 9 in Lianyungang Economic and Technological Development Zone.
The conference focused on how artificial intelligence can support pharmaceutical innovation and global cooperation.
An “Artificial Intelligence + Medicine” public service platform was launched at the opening ceremony.
The event brought together pharmaceutical experts, scholars and company representatives for forums, presentations and business discussions.
- Who
- Pharmaceutical experts, scholars and company representatives attended.
- What
- The eighth Lianyungang Pharmaceutical Technology Conference discussed AI-enabled pharmaceutical innovation and global cooperation.
- When
- November 8–9, 2026.
- Where
- Lianyungang Economic and Technological Development Zone, China.
- Why
- To bring together pharmaceutical innovation resources, deepen the use of AI in the industry and promote international cooperation.
This story does not have two clearly opposing sides.
The eighth Lianyungang Pharmaceutical Technology Conference was held in Lianyungang Economic and Technological Development Zone.
The “Artificial Intelligence + Medicine” public service platform was launched, and two industry platforms were unveiled.
- Conference edition
- Eighth Lianyungang Pharmaceutical Technology Conference
- Dates
- November 8–9, 2026
- Location
- Lianyungang Economic and Technological Development Zone
- Forum format
- One main forum and three sub-forums
- New platform
- Artificial Intelligence + Medicine” public service platform
1 source
What people are saying
The deep integration of artificial intelligence and biopharmaceuticals is becoming an important driving force for innovation and change in the industry.